Lupin's Pithampur facilities complete successful UK MHRA inspection

The inspection for the three units at Pithampur (Unit I, Unit II and Unit III) was conducted in January 2020, the pharma company said on Friday.

May 11, 2020 03:05 IST India Infoline News Service

Lupin
Pharma major Lupin has announced the successful close out of the inspection carried out by the Medicines and Healthcare Products Regulatory Agency (MHRA), the regulatory agency of the United Kingdom (UK), at its three manufacturing units in Pithampur (India).

The inspection for the three units at Pithampur (Unit I, Unit II and Unit III) was conducted in January 2020, the pharma company said on Friday.

Commenting on the positive outcome, Nilesh Gupta, Managing Director, Lupin said, “We are committed to maintaining truly global quality standards at all our manufacturing facilities. The successful close out of the inspection at Pithampur and release of the inspection report by UK MHRA further bolsters our confidence in our quality standards and manufacturing processes.”

Related Story